Back to Search
Start Over
Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii
- Publication Year :
- 2012
- Publisher :
- Elsevier, 2012.
-
Abstract
- Guvenc, Tolga/0000-0003-1468-3415; Aksoy, Abdurrahman/0000-0001-9486-312X WOS: 000308707500007 PubMed: 22831842 Due to increasing drug resistance, available antimicrobial options are limited in the treatment of Acinetobacter baumannii infections. Particularly in cases caused by extensively drug-resistant (XDR) A. baumannii, combination regimens must also be taken into consideration. In this study, the efficacies of tigecycline, colistin and tigecycline/colistin combination on bacterial counts in lung tissue were investigated in a rat pneumonia model. One A. baumannii strain resistant to all antimicrobial agents except tigecycline and colistin was selected for the study. In vivo studies revealed a >3 log reduction in bacterial counts in the tigecycline, colistin and combination groups at 24 h and 48 h compared with the control group. No significant differences were determined between colistin, tigecycline and combination groups (P > 0.05). On the other hand, differences between treatment groups and the control group were statistically significant (P = 0.01). A greater reduction in bacterial counts was observed at 48 h compared with 24 h in the tigecycline group than in the colistin group (P = 0.038 and P = 0.139, respectively); the most significant decrease between 24 h and 48 h was observed in the combination group (P = 0.014). Despite detection of in vitro synergistic activity in this study, no statistically significant differences were found between colistin, tigecycline and combination treatments in terms of efficacy on bacterial counts in lung tissue. In the treatment of infections with a high mortality rate such as pneumonia caused by XDR A. baumannii, combining tigecycline with colistin during the first 48 h and continuing treatment with one of these agents seems a rational approach. (C) 2012 Elsevier B. V. and the International Society of Chemotherapy. All rights reserved. Ondokuz Mayis University Commission of Scientific Research Projects (Samsun, Turkey)Ondokuz Mayis University [PYO.TIP.1904.10035] This study was supported by Ondokuz Mayis University Commission of Scientific Research Projects (Samsun, Turkey) (grant no. PYO.TIP.1904.10035).
- Subjects :
- Acinetobacter baumannii
Microbiology (medical)
Time Factors
XDR Acinetobacter baumannii
Minocycline
Tigecycline
Drug resistance
Microbiology
Pharmacotherapy
In vivo
Drug Resistance, Multiple, Bacterial
Pneumonia, Bacterial
polycyclic compounds
Animals
Medicine
Pharmacology (medical)
Rat pneumonia model
Rats, Wistar
Lung
biology
business.industry
Colistin
General Medicine
biochemical phenomena, metabolism, and nutrition
bacterial infections and mycoses
medicine.disease
Antimicrobial
biology.organism_classification
Bacterial Load
Anti-Bacterial Agents
Rats
Disease Models, Animal
Pneumonia
Treatment Outcome
Infectious Diseases
bacteria
Drug Therapy, Combination
Female
business
Acinetobacter Infections
medicine.drug
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....b9a7fb734caf400b1051f4752afdd48f